These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7679644)

  • 21. Class I-restricted alloreactive cytotoxic T lymphocytes recognize a complex array of specific MHC-associated peptides.
    Wang W; Man S; Gulden PH; Hunt DF; Engelhard VH
    J Immunol; 1998 Feb; 160(3):1091-7. PubMed ID: 9570521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alloreactive T cells can distinguish between the same human class II MHC products on different B cell lines.
    Santamaria P; Boyce-Jacino MT; Lindstrom AL; Rich SS; Faras AJ; Barbosa JJ
    J Immunol; 1991 Mar; 146(6):1822-8. PubMed ID: 1706381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.
    Valli A; Sette A; Kappos L; Oseroff C; Sidney J; Miescher G; Hochberger M; Albert ED; Adorini L
    J Clin Invest; 1993 Feb; 91(2):616-28. PubMed ID: 7679413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of a major T cell epitope of mycobacteria to a specific pocket within HLA-DRw17(DR3) molecules.
    Geluk A; Bloemhoff W; De Vries RR; Ottenhoff TH
    Eur J Immunol; 1992 Jan; 22(1):107-13. PubMed ID: 1370411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of two promiscuous T cell epitopes from tetanus toxin.
    Ho PC; Mutch DA; Winkel KD; Saul AJ; Jones GL; Doran TJ; Rzepczyk CM
    Eur J Immunol; 1990 Mar; 20(3):477-83. PubMed ID: 1690656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved sensitization of antigen-presenting cells with transferrin-bound peptides: advantages in competition for antigen presentation.
    Mauri D; Wyss-Coray T; Brander C; Pichler WJ
    Cell Immunol; 1994 Oct; 158(1):59-70. PubMed ID: 8087868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones.
    Meinl E; Weber F; Drexler K; Morelle C; Ott M; Saruhan-Direskeneli G; Goebels N; Ertl B; Jechart G; Giegerich G
    J Clin Invest; 1993 Dec; 92(6):2633-43. PubMed ID: 7504690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding.
    Busch R; Hill CM; Hayball JD; Lamb JR; Rothbard JB
    J Immunol; 1991 Aug; 147(4):1292-8. PubMed ID: 1869824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptide HER2(776-788) represents a naturally processed broad MHC class II-restricted T cell epitope.
    Sotiriadou R; Perez SA; Gritzapis AD; Sotiropoulou PA; Echner H; Heinzel S; Mamalaki A; Pawelec G; Voelter W; Baxevanis CN; Papamichail M
    Br J Cancer; 2001 Nov; 85(10):1527-34. PubMed ID: 11720440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Naturally processed cytokine-derived peptide bound to HLA-class II molecules.
    Harris PE; Maffei A; Liu Z; Colovai I; Reed EF; Inghirami G; Suciu-Foca N
    J Immunol; 1993 Dec; 151(11):5975-83. PubMed ID: 8245442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptides of 23 residues or greater are required to stimulate a high affinity class II-restricted T cell response.
    Srinivasan M; Domanico SZ; Kaumaya PT; Pierce SK
    Eur J Immunol; 1993 May; 23(5):1011-6. PubMed ID: 8386663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolution of the HLA-DR1 gene family. Structural and functional analysis of the new allele "DR-BON".
    Coppin HL; Avoustin P; Fabron J; Huchenq A; Garnier JM; Thomsen M; De Preval C
    J Immunol; 1990 Feb; 144(3):984-9. PubMed ID: 1688595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T cell epitopes encompassing the mutational hot spot position 61 of p21 ras. Promiscuity in ras peptide binding to HLA.
    Gedde-Dahl T; Spurkland A; Fossum B; Wittinghofer A; Thorsby E; Gaudernack G
    Eur J Immunol; 1994 Feb; 24(2):410-4. PubMed ID: 7507844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modified MHC restriction of donor-origin T cells in humans with severe combined immunodeficiency transplanted with haploidentical bone marrow stem cells.
    Roberts JL; Volkman DJ; Buckley RH
    J Immunol; 1989 Sep; 143(5):1575-9. PubMed ID: 2474604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells.
    Guéry JC; Adorini L
    J Immunol; 1995 Jan; 154(2):536-44. PubMed ID: 7529278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of T cell epitopes restricted by HLA-DP9 in streptococcal M12 protein.
    Dong RP; Kamikawaji N; Toida N; Fujita Y; Kimura A; Sasazuki T
    J Immunol; 1995 May; 154(9):4536-45. PubMed ID: 7536773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DR3-restricted T cells from different HLA-DR3-positive individuals recognize the same peptide (amino acids 2-12) of the mycobacterial 65-kDa heat-shock protein.
    Van Schooten WC; Elferink DG; Van Embden J; Anderson DC; De Vries RR
    Eur J Immunol; 1989 Nov; 19(11):2075-9. PubMed ID: 2480902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A peptide variant of an arthritis-related T cell epitope induces T cells that recognize this epitope as a synthetic peptide but not in its naturally processed form.
    Wauben MH; van der Zee R; Joosten I; Boog CJ; van Dijk AM; Holewijn MC; Meloen RH; van Eden W
    J Immunol; 1993 Jun; 150(12):5722-30. PubMed ID: 7685800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An analysis of synthetic peptide restriction by HLA-DR alleles in T cells from human subjects, naturally sensitized by Streptococcus mutans.
    Childerstone A; Altmann D; Haron JA; Wilkinson D; Trowsdale J; Lehner T
    J Immunol; 1991 Mar; 146(5):1463-9. PubMed ID: 1993839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonrandom T cell receptor usage in the allorecognition of HLA-DR1 microvariation.
    Hurley CK; Steiner N; Wagner A; Geiger MJ; Eckels DD; Rosen-Bronson S
    J Immunol; 1993 Feb; 150(4):1314-24. PubMed ID: 8381833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.